C07D 498/00
Heterocyclic compounds containing in the condensed system at least one hetero ring
Official title: Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (4-oxa-1-azabicyclo [3.2.0] heptanes, e.g. oxapenicillins C07D503/00; 5-oxa-1-azabicyclo [4.2.0] octanes, e.g. oxacephalosporins C07D505/00; analogues thereof having ring oxygen atoms in other position C07D507/00)
C07D498/00 (Heterocyclic compounds containing in the condensed system at least one hetero ring) appears on 5,791 US grants and 7,797 published applications in this corpus.
Search patents in C07D- Granted patents
- 5,791
- Published applications
- 7,797
- Assignees
- 2,235
- Inventors
- 18,701
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 14 | 0 |
| 1977 | 19 | 0 |
| 1978 | 15 | 0 |
| 1979 | 26 | 0 |
| 1980 | 30 | 0 |
| 1981 | 24 | 0 |
| 1982 | 23 | 0 |
| 1983 | 13 | 0 |
| 1984 | 6 | 0 |
| 1985 | 18 | 0 |
| 1986 | 16 | 0 |
| 1987 | 25 | 0 |
| 1988 | 32 | 0 |
| 1989 | 37 | 0 |
| 1990 | 39 | 0 |
| 1991 | 28 | 0 |
| 1992 | 43 | 0 |
| 1993 | 42 | 0 |
| 1994 | 33 | 0 |
| 1995 | 41 | 0 |
| 1996 | 64 | 0 |
| 1997 | 46 | 0 |
| 1998 | 43 | 0 |
| 1999 | 42 | 0 |
| 2000 | 38 | 0 |
| 2001 | 31 | 3 |
| 2002 | 41 | 53 |
| 2003 | 36 | 62 |
| 2004 | 30 | 71 |
| 2005 | 33 | 114 |
| 2006 | 46 | 106 |
| 2007 | 78 | 175 |
| 2008 | 76 | 170 |
| 2009 | 101 | 219 |
| 2010 | 117 | 274 |
| 2011 | 130 | 311 |
| 2012 | 211 | 324 |
| 2013 | 272 | 325 |
| 2014 | 306 | 393 |
| 2015 | 359 | 389 |
| 2016 | 295 | 405 |
| 2017 | 381 | 390 |
| 2018 | 299 | 362 |
| 2019 | 340 | 395 |
| 2020 | 310 | 431 |
| 2021 | 285 | 414 |
| 2022 | 251 | 433 |
| 2023 | 240 | 576 |
| 2024 | 265 | 559 |
| 2025 | 291 | 489 |
| 2026 | 210 | 354 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity6 Oct 2026US 12,753,171 B2Genzyme Corporation
- Sirt6 activators6 Oct 2026US 12,753,180 B2Board of Regents, The University of Texas System
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesviruses6 Oct 2026US 12,753,187 B2Merck Sharp & Dohme Corp.
- Substituted oxoisoindolinyl piperidine-2,6-dione compounds and aza analogs thereof8 Oct 2026US 2026/0308147 A1
- Tricyclic compounds for treatment of bacterial infections8 Oct 2026US 2026/0308172 A1Hoffmann-La Roche Inc.
- Oxazolopyridin-7(4h)-one wrn inhibitors8 Oct 2026US 2026/0308173 A1Nimbus Wadjet, Inc.
- Hexahydro[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine deuterated derivative, pharmaceutical composition thereof, preparation method therefor, and anti-influenza use thereof8 Oct 2026US 2026/0308174 A1Changsha Jingyi Pharmaceutical Technology Co., Ltd
- Imidazolium salt macrocyclic compound and preparation method therefor and use thereof8 Oct 2026US 2026/0308175 A1Fudan University
Most cited
By later US patents
- Process for preparing amide acetals1,464US 7,439,354 B2E. I. Du Pont de Nemours and Company · 2008
- Single-compartment, self-erasing, solution-phase electrochromic devices, solutions for use therein, and uses thereof555US 4,902,108 AGentex Corporation · 1990
- Fermentation process of preparing demethyl maytansinoids304US 4,361,650 ATakeda Chemical Industries, Ltd. · 1982
- Dechloromaytansinoids, their pharmaceutical compositions and method of use302US 4,256,746 ATakeda Chemical Industries, Ltd. · 1981
- Maytansinoids302US 4,322,348 ATakeda Chemical Industries, Ltd. · 1982